EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $230,000 | -10.2% | 4,300 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $256,000 | -25.4% | 4,300 | -1.1% | 0.01% | -37.5% |
| Q2 2017 | $343,000 | -2.6% | 4,350 | +2.4% | 0.01% | -11.1% |
| Q1 2017 | $352,000 | -10.2% | 4,250 | -14.1% | 0.01% | 0.0% |
| Q4 2016 | $392,000 | +13.3% | 4,950 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $346,000 | +80.2% | 4,950 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $192,000 | -1.0% | 4,950 | +3.1% | 0.01% | 0.0% |
| Q1 2016 | $194,000 | -54.4% | 4,800 | 0.0% | 0.01% | -57.1% |
| Q4 2015 | $425,000 | – | 4,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |